Sign in

CIK 0001601830

  • Large accelerated filer

RECURSION PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464099738
Phone
+1 385-269-0203
Business address
41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
Former names
Recursion Pharmaceuticals, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$701,222
in 5 filings, $701K under 10b5-1 plans

Net −$701,222. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-13 Secora Michael Chief Financial Officer Exercise or conversion 10b5-1 +39,375 $2.22 $87K 1,258,468
2024-06-13 Secora Michael Chief Financial Officer Sale 10b5-1 −15,000 $9.32 $140K 1,243,468
2024-06-13 Secora Michael Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −39,375 770,760
2024-06-11 Borgeson Blake Director Sale 10b5-1 −11,447 $8.45 $97K 7,188,563
2024-06-06 Gibson Christopher Chief Executive Officer Sale 10b5-1 −50,000 $9.00 $450K 708,738
2024-06-05 Gibson Christopher Chief Executive Officer Conversion 10b5-1 +100,000 908,738
2024-06-05 Gibson Christopher Chief Executive Officer Conversion · Class B Common Stock 10b5-1 −100,000 6,326,700
2024-06-05 Gibson Christopher Chief Executive Officer Conversion 10b5-1 +25,000 833,738
2024-06-05 Gibson Christopher Chief Executive Officer Gift 10b5-1 −25,000 808,738
2024-06-05 Gibson Christopher Chief Executive Officer Sale 10b5-1 −50,000 $8.42 $421K 758,738
2024-06-05 Gibson Christopher Chief Executive Officer Conversion · Class B Common Stock 10b5-1 −25,000 6,401,700
2024-06-03 Burrell Terry-Ann Director Grant or award +13,097 69,411
2024-06-03 Burrell Terry-Ann Director Grant or award · Stock Option (Right to Buy) +26,193 26,193
2024-06-03 HERSHBERG ROBERT Director Grant or award +13,097 51,716
2024-06-03 HERSHBERG ROBERT Director Grant or award · Stock Option (Right to Buy) +26,193 26,193
2024-06-03 Borgeson Blake Director Grant or award +13,097 7,200,010
2024-06-03 Borgeson Blake Director Grant or award · Stock Option (Right to Buy) +26,193 26,193
2024-06-03 Dar Zavain Director Grant or award +13,097 102,153
2024-06-03 Dar Zavain Director Grant or award · Stock Option (Right to Buy) +26,193 26,193
2024-06-03 Li Dean Y Director Grant or award +13,097 72,186

Page 19 of 41 · 805 trades